BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 24757675)

  • 21. Long noncoding RNA HULC promotes hepatocellular carcinoma progression.
    Zhang H; Liao Z; Liu F; Su C; Zhu H; Li Y; Tao R; Liang H; Zhang B; Zhang X
    Aging (Albany NY); 2019 Oct; 11(20):9111-9127. PubMed ID: 31645479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-expression of lncRNA CEBPA-AS1 promotes liver cancer progression.
    Wu C; Tang ZY; Chen HY; Zhang J; Zhao C
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8295-8302. PubMed ID: 31646559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA influence sequential steps of hepatocellular carcinoma metastasis.
    Lv E; Sheng J; Yu C; Rao D; Huang W
    Biomed Pharmacother; 2021 Apr; 136():111224. PubMed ID: 33450489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Cancer Cell Stemness-Associated Long Noncoding RNAs for Predicting Prognosis of Patients with Hepatocellular Carcinoma.
    Zhang Q; Cheng M; Fan Z; Jin Q; Cao P; Zhou G
    DNA Cell Biol; 2021 Aug; 40(8):1087-1100. PubMed ID: 34096799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
    Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
    Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating
    Kang CL; Qi B; Cai QQ; Fu LS; Yang Y; Tang C; Zhu P; Chen QW; Pan J; Chen MH; Wu XZ
    Theranostics; 2019; 9(15):4421-4436. PubMed ID: 31285770
    [No Abstract]   [Full Text] [Related]  

  • 28. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cells.
    He X; Zheng Y; Zhang Y; Gan Y; Zhou Y; Liang H; Wu D; Ge W; Deng J; Xu X
    Oncotarget; 2017 Feb; 8(6):9451-9465. PubMed ID: 28035067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma.
    Moyo B; Nicholson SA; Arbuthnot PB
    Virus Res; 2016 Jan; 212():103-13. PubMed ID: 26239319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the role of exosome-derived long non-coding RNAs in hepatocellular carcinoma].
    Zhou C; Wang CJ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):77-81. PubMed ID: 30685932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
    Yin J; Liu Q; Chen C; Liu W
    J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma.
    Kim YA; Park KK; Lee SJ
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
    Fan L; Huang X; Chen J; Zhang K; Gu YH; Sun J; Cui SY
    Mol Cancer Ther; 2020 May; 19(5):1197-1209. PubMed ID: 32220970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression.
    Zhong JH; Xiang X; Wang YY; Liu X; Qi LN; Luo CP; Wei WE; You XM; Ma L; Xiang BD; Li LQ
    J Cell Physiol; 2020 Feb; 235(2):1090-1102. PubMed ID: 31256427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.